INVO Fertility, Inc. (IVF): debt financing — INVO Bioscience sells $344,925 of future receipts for $236,250; net proceeds $225,000

INVO Fertility, Inc.

Net proceeds of $225,000 from sale of future receipts; total repayment amount is $344,925.
Weekly payments of $13,797 due until purchase price is fully repaid.
Proceeds to be used for working capital and general corporate purposes.
Transaction structured as a purchase and sale of future receipts, not a traditional loan.

item 1.01 item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

INVO Fertility, Inc. incurred debt of $344,925 with Buyer maturing Until the purchase price has been repaid.

Principal: $344,925
Counterparty: Buyer
Maturity: Until the purchase price has been repaid
Event: incurrence

Exact text from the filing

On February 26, 2024, INVO Bioscience, Inc. (the “Company”) finalized an Agreement for the Purchase and Sale of Future Receipts (the “Future Receipts Agreement”) with a buyer (the “Buyer”) under which the Buyer purchased $344,925 of our future sales for a gross purchase price of $236,250.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INVO Fertility, Inc. entered into Agreement for the Purchase and Sale of Future Receipts with Buyer valued at $236,250 (effective 2024-02-26).

Action: entry
Agreement: asset purchase
Counterparty: Buyer
Value: $236,250
Effective: 2024-02-26

Exact text from the filing

On February 26, 2024, INVO Bioscience, Inc. (the “Company”) finalized an Agreement for the Purchase and Sale of Future Receipts (the “Future Receipts Agreement”) with a buyer (the “Buyer”) under which the Buyer purchased $344,925 of our future sales for a gross purchase price of $236,250.

View on SEC.gov

299 debt financings filed in the last 30 days. Browse all debt financings →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-008576

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.